Lupin was founded on the auspicious ‘Guddi padwa’ Day in 1968 by Dr. Desh Bandhu Gupta - a visionary with a compelling mission to create a better world for people. DBG as he was fondly called, started the company with a dream - a dream to fight life-threatening, infectious diseases with affordable and high-quality drugs of the highest social priority. With his vision, inimitable commitment and passion, Dr. Gupta steered the organization to become one of the fastest-growing Generic pharmaceutical companies around the world.The name ‘Lupin’ was inspired by the flower Lupin which is known to nourish the soil it grows in.

The Lupin flower is also known to be tolerant of the infertile soils and capable of pioneering change in barren and poor climates. This inspiration is at the core of the company’s ethos as it relentlessly strives to build medical solutions to meet the unmet needs of the society not just for a few but for the many across the globe.

Lupin is recognised as one of the world's largest manufacturers of Tuberculosis drugs. The company have significant market share across multiple therapy areas such as Cardiovascular (prils and statins), Diabetology, Asthma, Paediatric, Central Nervous System (CNS), Gastro Intestinal (GI), Anti-Infective (AI) and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). To add to this, the company has proud to maintain over the years its global leadership positions in other therapy areas such as Anti-TB and Cephalosporin.

Business area of the company

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Ltd.

Biocon Ltd.

Alkem Laboratories Ltd.

Gland Pharma Ltd.

Zydus Lifesciences Ltd.

Abbott India Ltd.

Aurobindo Pharma Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

Laurus Labs Ltd.

Ipca Laboratories Ltd.

Piramal Enterprises Ltd.

Pfizer Ltd.

Ajanta Pharma Ltd.

JB Chemicals & Pharmaceuticals Ltd.

Torrent Pharmaceuticals Ltd.

HDFC Bank Ltd.

ICICI Bank Ltd.

ITC Ltd.

Reliance Industries Ltd.

Tata Motors Ltd.

Market Cap	35,019 Cr		EPS	16.7		High	769.6
Stock P/E	46.1		Net Profit Margin	3.2		Low	762

LUPIN